In gliomas with a mutation of the isocitrate dehydrogenase gene (IDH-mutation), decreased expression of the T cell-attracting chemokines CXCL9 and CXCL10 was found, resulting in reduced migration of CD8+ T cells to tumors in vitro. This evidence concerns the gene CXCL9 and central nervous system cancer.